Literature DB >> 2407244

Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.

O H Drummer1, S Kourtis, H Johnson.   

Abstract

We have investigated the effect of chronic administration of enalapril on the carboxypeptidases responsible for the formation of angiotensin II from angiotensin I and other peptidases known to recognize angiotensin I as a substrate in the rat. These studies have shown an increase in activity in rate of formation of des-Leu-angiotensin I in both kidney S2 and P2 centrifugal fractions as well as a decrease in the rate of degradation of angiotensin I substrate. Similar increases in the formation of A(1-8) have been observed in kidney using A(1-9) as substrate. These two enzyme activities have been named carboxypeptidase K1 and K2, respectively to reflect their presence in rat kidney. These changes were accompanied by significant decreases in the activity of an amastatin-sensitive aminopeptidase and endopeptidase 24.11 in the kidney P2 fraction. These data suggest that chronic treatment with ACE inhibitors may differentially affect the activity of other enzymes capable of degrading angiotensin causing a substantial re-direction of angiotensin metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407244     DOI: 10.1016/0006-2952(90)90058-s

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

Review 1.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

2.  Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.

Authors:  María Paz Ocaranza; Jorge E Jalil
Journal:  Int J Hypertens       Date:  2012-01-19       Impact factor: 2.420

Review 3.  Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.

Authors:  Devang M Patel; Madhura Bose; Mark E Cooper
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

Review 4.  Vaccines against components of the renin-angiotensin system.

Authors:  Noé Francisco Garay-Gutiérrez; Carolina Paz Hernandez-Fuentes; Gerardo García-Rivas; Sergio Lavandero; Carlos Enrique Guerrero-Beltrán
Journal:  Heart Fail Rev       Date:  2020-09-29       Impact factor: 4.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.